Advertisement

Topics

Pool Corporation CEO and CFO to Attend the William Blair 35th Annual Growth Stock Conference

20:00 EDT 3 Jun 2015 | Globe Newswire

COVINGTON, La., June 04, 2015 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq:POOL) announced today that Manuel Perez de la Mesa, President and CEO, will be presenting at the William Blair 35th Annual Growth Stock Conference at the Four Seasons Hotel in Chicago, IL.  Mark W. Joslin, CFO, will also be attending the conference.  Mr. Perez de la Mesa is slated to present on June 11, 2015 at 9:20 am Central.  The presentation slides will be posted on POOLCORP’s website at that time.

Pool Corporation is the world's largest wholesale distributor of swimming pool and related backyard products.  Currently, POOLCORP operates 330 sales centers in North America, Europe, South America and Australia, through which it distributes more than 160,000 national brand and private label products to roughly 100,000 wholesale customers.  For more information about POOLCORP, please visit www.poolcorp.com.
           
This news release may include “forward-looking” statements that involve risk and uncertainties.  The forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Actual results may differ materially due to a variety of factors, including the sensitivity of the swimming pool supply business to weather conditions and other risks detailed in POOLCORP’s 2014 Form 10-K filed with the Securities and Exchange Commission.


CONTACT:

Craig K. Hubbard
Investor Relations
985.801.5117
craig.hubbard@poolcorp.com

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Pool Corporation CEO and CFO to Attend the William Blair 35th Annual Growth Stock Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...